Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome

Clinical trial NCT06256432 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06256432
Sponsor: Noorik Biopharmaceuticals AG
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatorenal Syndrome Liver Cirrhosis Acute Kidney Injury Ascites Hepatic

Start date: 2024-04-17
Primary completion: 2026-05-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.